Physician profile
Michael Binstock
NPI 1083795132
$615.86
in general payments reported to CMS, 2019-2025
19 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $195 · 2022: $113 · 2023: $103 · 2024: $26.25 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $79.27 | 2021-2022 | |
| Integra Lifesciences Corporation | $68.61 | 2021-2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Boston Scientific Corporation | $54.42 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $54.37 | 2024-2025 | |
| Smith+Nephew, INC. | $51.64 | 2022-2023 | Pico 7, Renasys Go V2 Home, Pico 14 |
| Hologic Sales and Service, LLC | $39.64 | 2022-2025 | Sentimag |
| Myriad Genetic Laboratories, INC. | $34.60 | 2021-2025 | Myrisk |
| Kerecis Limited | $34.02 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tela Bio, INC. | $26.62 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.75 | 2021 | |
| Axogen | $24.68 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $20.50 | 2025 | Exparel |
| Hydrofera LLC | $17.86 | 2023 | Hydrofera Blue |
| Solventum Corporation | $17.17 | 2025 | V.A.C. Veraflo, Prevena |
| Baxter Healthcare | $14.16 | 2025 | Perclot |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.03 | 2021 | |
| La Jolla Pharmaceutical Company | $13.76 | 2023 | Xerava |
| Ethicon US, LLC | $13.69 | 2025 | Stratafix, Dermabond Prineo |
| Aroa Biosurgery Incorporated | $11.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Binstock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.